SG Americas Securities’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SG Americas Securities’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$369K	–	3660
2020 Q4	$369K	Buy	+30,000	New	+$2.25M	﹤0.01%	2220

SG Americas Securities's ARNA Position: Q1 2022 in Review

SG Americas Securities sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,403 shares — an estimated $316K sold.

SG Americas Securities first reported a position in ARNA in Q2 2013 and held it in 31 quarters. The position peaked at $3.37M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

SG Americas Securities reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
SG Americas Securities sold 3,403 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $316K.
SG Americas Securities first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
SG Americas Securities's Arena Pharmaceuticals Inc position peaked at $3.37M in Q2 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.